Bio-Path (BPTH) Stock Chart & Stock Price History $0.11 -0.01 (-11.67%) As of 11:03 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsFDA EventsHeadlinesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock Bio-Path Stock Price Performance The Bio-Path (BPTH) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 91.62%, with a year-to-date return of -90.86%. In the past month, the stock has decreased 31.61%, reflecting recent market activity. As of the latest close, Bio-Path traded at $0.12 with a market cap of $997 thousand and volume of 4,504 shares. Five years ago, the stock traded at a split-adjusted price of $103.20, representing a 99.90% decrease over that period. At the time, it had a market cap of $15.65 million and a volume of 306,388 shares. Receive BPTH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bio-Path and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-18.59%1 Month Performance-31.61%3 Month Performance-39.77%Year-To-Date Performance-90.86%1 Year Performance-91.62%5 Year Performance-99.90% BPTH Stock Chart for Friday, August, 22, 2025 BPTH Chart by TradingView Bio-Path Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$0.12$0.12$0.12$0.104,504 shs$997,000.0008/20/2025$0.11$0.12+10.09%$0.12$0.09118,401 shs$997,000.0008/19/2025$0.13$0.11-15.04%$0.14$0.09134,106 shs$906,000.0008/18/2025$0.13$0.13-1.46%$0.15$0.1336,771 shs$1.07 million08/15/2025$0.14$0.13-5.31%$0.13$0.133,220 shs$1.08 million08/14/2025$0.14$0.14-1.79%$0.14$0.131,420 shs$1.14 million08/13/2025$0.14$0.14$0.15$0.1411,502 shs$1.16 million08/12/2025$0.14$0.14$0.14$0.1327,508 shs$1.16 million08/11/2025$0.14$0.14$0.15$0.1429,601 shs$1.16 million08/08/2025$0.14$0.14$0.15$0.1476,079 shs$1.16 million Get the Latest News and Ratings for BPTH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bio-Path and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$0.14$0.14$0.14$0.1450,579 shs$1.16 million08/06/2025$0.14$0.14-3.38%$0.14$0.1423,006 shs$1.16 million08/05/2025$0.14$0.14$0.14$0.1416,895 shs$1.20 million08/04/2025$0.15$0.14-4.92%$0.15$0.1413,349 shs$1.20 million08/01/2025$0.15$0.15+1.60%$0.15$0.1511,517 shs$1.27 million07/31/2025$0.15$0.15-1.19%$0.15$0.156,181 shs$1.25 million07/30/2025$0.15$0.15-2.00%$0.15$0.154,612 shs$1.26 million07/29/2025$0.15$0.15+1.51%$0.15$0.1517,150 shs$1.29 million07/28/2025$0.15$0.15+4.52%$0.15$0.1513,440 shs$1.27 million07/25/2025$0.16$0.15-5.81%$0.16$0.1598,295 shs$1.21 million07/24/2025$0.16$0.16-1.90%$0.16$0.1630,967 shs$1.29 million07/23/2025$0.16$0.16+1.94%$0.16$0.1696,056 shs$1.31 million07/22/2025$0.16$0.16-1.27%$0.16$0.16165,278 shs$1.29 million07/21/2025$0.16$0.16+0.64%$0.16$0.1637,414 shs$1.30 million Related Companies VIVS Stock Price Chart GLTO Stock Price Chart INM Stock Price Chart CPHI Stock Price Chart XBIO Stock Price Chart CMND Stock Price Chart ALBT Stock Price Chart DRMA Stock Price Chart INDP Stock Price Chart JAGX Stock Price Chart Receive BPTH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bio-Path and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BPTH) was last updated on 8/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredOne tiny company just cracked Google’s $19B problemGoogle’s AI-powered search could cost $20 billion a year in electricity—nearly half its profits. But new resea...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Path Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Path With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access